results- what results, page-5

Oldkat,

No news will flow if the company is in discussions,the only news will maybe the qtr reports.

As for the share price hitting 14C it could be the following-

Invion engages Numoda Corporation for clinical trial management services for INV102 and INV103 phase II clinical trials

? Numoda Capital Innovations, LLC to invest in Invion via private placements and open market purchases.BRISBANE, 20 DECEMBER 2012:
NCI’s total commitment under the agreement is for an investment of up to $2 million to occur across
current and future clinical trials. The alliance provides Invion access to Numoda’s TruPoints
technology which will organize the due diligence material coming from Invion’s forthcoming clinical
trials in smoking cessation and lupus. The patented technology will enable Invion to facilitate the flow
of business, contract manufacturing and “live” clinical trial information to potential collaborative and
commercial partners without incurring a statistical penalty.

The Board of Invion estimates the value of shares to be purchased and placed relative to these two
clinical trials being conducted over the next NCI’s total commitment under the agreement is for an investment of up to $2 million to occur across
current and future clinical trials. The alliance provides Invion access to Numoda’s TruPoints
technology which will organize the due diligence material coming from Invion’s forthcoming clinical
trials in smoking cessation and lupus. The patented technology will enable Invion to facilitate the flow
of business, contract manufacturing and “live” clinical trial information to potential collaborative and
commercial partners without incurring a statistical penalty.

The Board of Invion estimates the value of shares to be purchased and placed relative to these two
clinical trials being conducted over the next twelve months will be in the order of $250,000.